Protara Therapeutics (TARA) Non-cash Items (2013 - 2026)

Protara Therapeutics' Non-cash Items history runs 14 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Non-cash Items fell 20.5% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (down 20.5% YoY), while the FY2025 annual figure was $2.9 million, up 47.95% from the prior year.
• Non-cash Items was $3.4 million for Q1 2026 at Protara Therapeutics, up from $2.9 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $9.0 million in Q4 2024 to a low of $4.8 in Q4 2022.
• Historically, Non-cash Items has averaged $2.0 million across 5 years, with a median of $1.3 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items tumbled 100.0% in 2023, then surged 9943898.79% in 2024.
• A 5-year view of Non-cash Items shows it stood at $4.8 in 2022, then jumped by 416566.67% to $20000.0 in 2023, then jumped by 44810.0% to $9.0 million in 2024, then slumped by 67.66% to $2.9 million in 2025, then advanced by 15.63% to $3.4 million in 2026.
• The last three Non-cash Items figures came in at $3.4 million (Q1 2026), $2.9 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.